NPCE vs RL · rev $79.9M vs P/E 24, rev $8.11B
Neuropace Inc (NPCE) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
NPCE currently screens at market cap $312.2M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the NPCE and RL stock pages for the full models.
Not investment advice.